Sort
261,768 grants matching “gene therapy”
Deconstructing aging with senolytic CAR T cells
$960,000Corina Amor Vegas · Cold Spring Harbor Laboratory · DP5 · FY2025 · OD
New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation
$960,000Rishi Arora · Northwestern University At Chicago · R35 · FY2023 · HL
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
$960,000Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2020 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2016 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2017 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · CA
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
$959,885M. Celeste Simon · University Of Pennsylvania · R35 · FY2021 · CA
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
$959,881M. Celeste Simon · University Of Pennsylvania · R35 · FY2020 · CA
The Antigen Targeting Core
$959,871Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
$959,860Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG
Novel Gene Editing Approaches for Hemoglobinopathies
$959,786Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2017 · HL
Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD
$959,682Darren G Woodside · Aviara Pharmaceuticals, Inc. · R42 · FY2024 · DK
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$959,618Laura D Attardi · Stanford University · R35 · FY2025 · CA
Antibody-based Protection against Flavivirses
$959,574Michael S. Diamond · Washington University · R01 · FY2019 · AI
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$959,550Jonah B. Sacha · Oregon Health & Science University · R01 · FY2020 · AI
MECHANISMS OF LIPODYSTROPHY IN HIV INFECTED PATIENTS
$959,511University Of Texas Sw Med Ctr/Dallas · R01 · FY2001 · DK
MODEL SYSTEMS TOWARD DEVELOPMENT OF HUMAN GENE THERAPY
$959,390University Of Pittsburgh At Pittsburgh · P01 · FY2000 · DK
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2022 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2023 · AI
Targeting Tumor Suppressor Phosphatases For Cancer Therapy
$959,368Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · U01 · FY2011 · CA
Biomarker Investigations for Clinical Trials
$959,273Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$959,257Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy
$959,212Asrar B. Malik · Cell Biologics, Inc. · R42 · FY2017 · HL
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
$959,147Hal E. Broxmeyer · Indiana University Indianapolis · U54 · FY2018 · DK